Skip to the content
-
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Compass Diversified Announces Appointment of Eric Weis as President of PrimaLoft; Elevation of Shawn Neville to PrimaLoft Board Chair
-
ACORE CAPITAL Announces Closing of $1.1 Billion Commercial Real Estate CLO
-
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
-
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
-
Outdoor Holding Company Reaches Settlement with Digital Cash Processing
-
Where Will We Get the Energy?
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
-
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
-
IQM, a Global Leader for Quantum Computing, to Become the First Listed European Quantum Company, Through Merger with Real Asset Acquisition Corp.
-
Dominion Energy announces 2025 financial results
-
Dominion Energy announces 2025 financial results
-
Triumph to Present at the Raymond James 47th Annual Institutional Investors Conference on March 3, in Orlando, FL
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Lumen Ratings Upgraded by Top 3 Global Ratings Agencies